You are here

Cancer Res DOI:10.1158/0008-5472.CAN-21-0791

Gene fusions create partner and collateral dependencies essential to cancer cell survival.

Publication TypeJournal Article
Year of Publication2021
AuthorsGillani, R, Seong, BKyung A, Crowdis, J, Conway, JR, Dharia, NV, Alimohamed, S, Haas, BJ, Han, K, Park, J, Dietlein, F, He, MXiao, Imamovic, A, Ma, C, Bassik, MC, Boehm, JS, Vazquez, F, Gusev, A, Liu, D, Janeway, KA, McFarland, JM, Stegmaier, K, Van Allen, EM
JournalCancer Res
Date Published2021 Jun 07
ISSN1538-7445
Abstract

Gene fusions frequently result from rearrangements in cancer genomes. In many instances, gene fusions play an important role in oncogenesis; in other instances, they are thought to be passenger events. Although regulatory element rearrangements and copy number alterations resulting from these structural variants (SV) are known to lead to transcriptional dysregulation across cancers, the extent to which these events result in functional dependencies with an impact on cancer cell survival is variable. Here we used CRISPR-Cas9 dependency screens to evaluate the fitness impact of 3,277 fusions across 645 cell lines from the Cancer Dependency Map (DepMap). We found that 35% of cell lines harbored either a fusion partner dependency or a collateral dependency on a gene within the same topologically associating domain (TAD) as a fusion partner. Fusion-associated dependencies revealed numerous novel oncogenic drivers and clinically translatable alterations. Broadly, fusions can result in partner and collateral dependencies that have biological and clinical relevance across cancer types.

DOI10.1158/0008-5472.CAN-21-0791
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/34099491?dopt=Abstract

Alternate JournalCancer Res
PubMed ID34099491